Menopausal hormone therapy (MHT) does not raise breast cancer risk in women with breast cancer gene mutations, while estrogen only MHT leads to reduced risk.

Research by University of Sydney scientists has uncovered a mechanism that may explain why glioblastoma returns after ...

Pairing a drug that targets the PRDM9 gene with a cholesterol-lowering agent shrank brain tumors and improved survival in mice.

Tokenization is emerging as a cornerstone of modern data security, helping businesses separate the value of their data from ...

A study by University of Sydney scientists has discovered why patients with glioblastoma often relapse, identifying a hidden ...

Menin inhibitors target the interaction between menin and the KMT2A complex, offering a breakthrough in treating acute ...

Genetic factors account for much of the variation in personality traits across the lifespan. Shared upbringing plays a ...

While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...

World-first research published today by University of Sydney scientists has uncovered a mechanism that may explain why glioblastoma returns after ...

The Every Woman study- Low and low-middle-income country edition, published  in the prestigious journal The Lancet on 11th ...

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor: Our Bureau, Mumbai Monday, December 15, 2025, 17:10 Hrs [IST] Funded by th ...

Researchers at the University of Sydney have identified how a fertility gene, PRDM9, enables drug-tolerant persister cells in ...